Director / PDMR dealings

RNS Number : 9237Y

Oxford Biomedica PLC

08 March 2012

 



OXFORD BIOMEDICA PLC

Director / PDMR dealings

Oxford, UK - 8 March 2012: Oxford BioMedica plc ("Oxford BioMedica" or "the Company") (LSE: OXB), the leading gene-based biopharmaceutical company, was informed on 7 March 2012 that two of its directors had acquired ordinary shares of 1p each ("Ordinary Shares") at a price of 3.022273p per Ordinary Share.

							Interest after purchase
Director / PDMR		Title		Price	Number of Ordinary Shares acquired on 07 March 2012		Number of Ordinary Shares		% of total issued share capital
Timothy Watts		CFO		3.022273p	1,000,000		1,000,000		0.1%
Paul Blake		NED		3.022273p	100,000		300,000		0.03%

The issued share capital of the Company is 944,875,557 1p ordinary shares.

For further information please contact:

For further information, please contact:
Oxford BioMedica plc: John Dawson, Chief Executive Officer Tim Watts, Chief Financial Officer Lara Mott, Head of Corporate Communications	Tel: [phone]
Singer Capital Markets Limited: Shaun Dobson/Claes Spång	Tel: [phone]

 

END

 

 

RDSLLFFTVIIDIIF